AzurRx BioPharma Inc News - AZRX

Securities Registration Statement (simplified Form) (s-3)

As filed with the Securities and Exchange Commission on December 2, 2022 Registration No. 333- ...

Current Report Filing (8-k)

0001604191 false 0001604191 2022-11-30 2022-11-30 iso4217:USD xbrli:shares...

Current Report Filing (8-k)

0001604191 false --12-31 0001604191 2022-11-25 2022-11-25 iso4217:USD...

Securities Registration (section 12(g)) (8-a12g)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...

Current Report Filing (8-k)

0001604191 false 0001604191 2022-11-20 2022-11-20 iso4217:USD xbrli:shares...

Quarterly Report (10-q)

98.0011.53289.31P0YP0Y2307008495194631.34662.25First Wave BioPharma, Inc.0001604191--12-312022Q3falseP9M02307008495194631.34662.2500http://fasb.org...

Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)

Filed Pursuant to Rule 424(b)(4) Registration No. 333-267423 PROSPECTUS 25...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:October 06, 2022...

Securities Registration Statement (s-1/a)

As filed with the Securities and Exchange Commission on September 22, 2022 Registration No. 333-267423...

Securities Registration Statement (s-1)

As filed with the Securities and Exchange Commission on September 14, 2022 Registration No. 333- ̳...

Current Report Filing (8-k)

0001604191 false --12-31 0001604191 2022-08-25 2022-08-25 iso4217:USD...

Quarterly Report (10-q)

2180733378124401869330666799180.251.630.826.39P0YP0Y2269981214855848631.34662.2500First Wave BioPharma, Inc.0001604191--12-312022Q2false7317P9M0226...

Notice of Effectiveness (effect)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 NOTICE OF EFFECTIVENESSEffective Date:August 04, 2022...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Filed Pursuant to Rule 424(b)(3) Registration No. 333-266375 PROSPECTUS 4,120,000 Shares...

Current Report Filing (8-k)

0001604191 false 0001604191 2022-07-29 2022-07-29 iso4217:USD xbrli:shares...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

AzurRx BioPharma Inc (AZRX)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

AZRX News

Securities Registration Statement (simplified Form) (s-3)

Current Report Filing (8-k)

Current Report Filing (8-k)

Securities Registration (section 12(g)) (8-a12g)

Current Report Filing (8-k)

Quarterly Report (10-q)

Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)

Notice of Effectiveness (effect)

Securities Registration Statement (s-1/a)

Securities Registration Statement (s-1)

Current Report Filing (8-k)

Quarterly Report (10-q)

Notice of Effectiveness (effect)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Current Report Filing (8-k)

AZRX Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

AzurRx BioPharma Inc (AZRX) News

AzurRx BioPharma Inc (AZRX)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

AZRX News

Securities Registration Statement (simplified Form) (s-3)

Current Report Filing (8-k)

Current Report Filing (8-k)

Securities Registration (section 12(g)) (8-a12g)

Current Report Filing (8-k)

Quarterly Report (10-q)

Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)

Notice of Effectiveness (effect)

Securities Registration Statement (s-1/a)

Securities Registration Statement (s-1)

Current Report Filing (8-k)

Quarterly Report (10-q)

Notice of Effectiveness (effect)

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Current Report Filing (8-k)

AZRX Discussion

Your Recent History